Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-813
Closed -$44K 7428
2020
Q3
$44K Sell
813
-59
-7% -$3.24K ﹤0.01% 5681
2020
Q2
$42K Buy
872
+465
+114% +$20.5K ﹤0.01% 6127
2020
Q1
$14K Sell
407
-3,311
-89% -$182K ﹤0.01% 6886
2019
Q4
$233K Buy
3,718
+3,602
+3,105% +$204K ﹤0.01% 5060
2019
Q3
$6K Sell
116
-58
-33% -$2.74K ﹤0.01% 7267
2019
Q2
$8K Buy
+174
New +$8.38K ﹤0.01% 7361

Other funds holding ENOV

Citigroup's ENOV Position: Q2 2026 in Review

Citigroup increased its Enovis (ENOV) stake by 3,865% in Q2 2026, buying an estimated $8.85M and bringing the position to 385,220 shares worth $7.97M. The position accounts for ﹤0.01% of the portfolio, ranked #1774.

Citigroup first reported a position in ENOV in Q2 2013 and has held it in 53 quarters since. The position peaked at $12.5M in Q1 2025. 253 funds tracked by Wall St. Rank hold ENOV as of Q2 2026.

  • Citigroup held 385,220 shares of Enovis worth $7.97M as of Q2 2026.
  • Citigroup bought 375,505 Enovis shares in Q2 2026, an estimated $8.85M.
  • Enovis made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #1774 holding.
  • Citigroup first reported a position in Enovis in Q2 2013 and has held it in 53 quarters since.
  • Citigroup's Enovis position peaked at $12.5M in Q1 2025.
  • 253 funds tracked by Wall St. Rank held Enovis as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.